ASRT - assertiotx.com Profit before interest, taxes and amortization
Regulatory threats and macroeconomic downturns are offset by the stabilization of the product portfolio, with the value maintained at 3.85. Historical EBITDA_Co data confirm the ability of Assertio Holdings, Inc. (ASRT) to maintain liquidity during market drawdowns. Risks are minimized through the acquisition of niche brands and synergy with distributors, as well as through licensing agreements that expand patient access to innovative medicines.
Summary analytical data breakdowns for Assertio (ASRT)
- stock value and consensus price forecast:
- market capitalization statistics:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Capital Coefficient Assertio Holdings, Inc.|ASRT - Long-Term Debt to Equity|Current Liabilities to Capital Assertio Holdings|ASRT - Company Total Debt|Debt to Net Assets Ratio Assertio|ASRT - Company Long-Term Debts|Company Short-Term Loans and Borrowings Assertio|Immediate Liquidity assertiotx.com
- earnings and market ratios statistics:
ASRT - Company Net Income|Expected Profit Assertio Holdings, Inc.|ASRT - P/E Multiple|Price to Future Earnings Ratio Assertio Holdings|ASRT - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Assertio|ASRT - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Assertio|ASRT - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year assertiotx.com|ASRT - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Assertio Holdings, Inc.
Fundamental company valuation:Assertio Holdings, Inc.
Analyzing quarterly EBITDA volume on the GURU.Markets platform allows for an assessment of Assertio Holdings, Inc. (ASRT) monetization efficiency of its patent portfolio amid pressure from generics. This indicator measures net cash flow from core operations, excluding the impact of inflationary costs and accounting adjustments, which helps investors distinguish sustainable operational output from random financial spikes when valuing the business.
Who Assertio Holdings, Inc. competes with
Operating income before deduction of amortization Biogen Idec (BIIB)|Neurocrine Biosciences - Operating profit EBITDA|Profit before interest, taxes and amortization regencellbioscience.com|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|ACADIA Pharma - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization XENE|VKTX (Viking Therapeutics Corp) - Company profit before taxes, interest and amortization|Operating profit EBITDA SUPN|Operating income before deduction of amortization catalystpharma.com|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|Harmony Biosciences Inc (HRMY) - Profit before interest, taxes and amortization|BHVN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AMLX (Amylyx Corp)|TRVI: Operating profit EBITDA|praxismedicines.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Anavex Life Sciences Corp.|Profit before interest, taxes and amortization CeriBell Inc CBLL|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|Profit before payment of interest, taxes and amortization ALEC (alector.com)|Operating profit EBITDA ANNX (Annexon, Inc.)|OMER: Operating profit before amortization|Neurogene - Operating profit EBITDA|Operating income before deduction of amortization AC Immune S.A. ACIU|Voyager Pharma (VYGR) - Profit before payment of interest, taxes and amortization|Operating profit before amortization NMRA|SCLX (Scilex Holding Company) - Operating profit EBITDA|TVGN - Operating profit before depreciation charges|Profit before payment of interest, taxes and amortization Alpha Cognition (ACOG)|Operating income before deduction of amortization Cognition Therapeutics Inc.|Inhibikase - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization SAVA|Coya - Operating profit EBITDA|Operating income before deduction of amortization Vistagen Therapeutics VTGN|ovidrx.com (OVID) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ABOS|CRVO (CervoMed Inc) - Operating profit EBITDA|Operating profit before deduction of amortization Alterity Therapeutics Ltd (ATHE)|Operating profit before deduction of amortization CLNN (Clene Inc.)|Operating income before deduction of amortization pepgen.com|Operating profit EBITDA JUNS (Jupiter Neurosciences)|Operating profit EBITDA Relmada Therapeutics Inc RLMD|ANVS - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Grace Therapeutics, Inc. GRCE|Firefly Neuroscience, Inc (AIFF) - Profit before payment of interest, taxes and amortization|Klotho Neurosciences - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization NRSN|RVPH (Reviva Pharmaceuticals Holdings Inc.) - Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NeurAxis Inc - Operating profit before amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|Passage Bio Inc. (PASG) - Profit before interest, taxes and amortization|NEUP: Operating profit before deduction of amortization|NERV - Operating profit EBITDA|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Addex - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Profit before interest, taxes and amortization Cyclerion CYCN|Operating profit EBITDA PTIX|Operating profit EBITDA pasitheaclinics.com (KTTA)|Profit before payment of interest, taxes and amortization Cortigent CRGT|Operating income before deduction of amortization Avenue Therapeutics Inc (ATXI)|BCLI - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization caratherapeutics.com CARA|CHRO: Operating profit EBITDA|Profit before interest, taxes and amortization Eliem Therapeutics Inc. (ELYM)|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|LBPH: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization MRNS (Marinus Pharmaceuticals)|Company profit before taxes, interest and amortization NKGN|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Operating income before deduction of amortization Sage Therapeutics Inc. (SAGE)|SNPX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Trevena Inc|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|anewmeds.com - Income before deduction of interest, taxes and amortization|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
